| mRNA |
PI-103 |
GDSC1000 |
pan-cancer |
AAC |
-0.0049 |
0.9 |
| mRNA |
BIRB 0796 |
GDSC1000 |
pan-cancer |
AAC |
0.0056 |
0.9 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
-0.0054 |
0.9 |
| mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
0.005 |
0.9 |
| mRNA |
XMD8-85 |
GDSC1000 |
pan-cancer |
AAC |
0.0079 |
0.9 |
| mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0051 |
0.9 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0049 |
0.9 |
| mRNA |
isoevodiamine |
CTRPv2 |
pan-cancer |
AAC |
-0.0047 |
0.9 |
| mRNA |
AT-7519 |
GDSC1000 |
pan-cancer |
AAC |
0.0043 |
0.9 |
| mRNA |
FGIN-1-27 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.9 |